Menu
0
0

Your Cart is Empty

Posters

Main menu

Infographics

  • Revealing Immune Responses with Adaptive Immune Receptor Repertoire Profiling (View)
  • Connecting Phenotype to Genotype with Functional Gene Screening (View)
  • CRISPR-Cas: The Next Generation (View)

Scientific Posters

  • NEW! Single-cell TCRα/β and TCRγ/δ immune receptor profiling and immunophenotyping using a 96-well plate sorted-cell approach, June 2024 (PDF)
  • NEW! Integrated transcriptomic and immune repertoire analysis reveals innate and adaptive immune response to vaccination, June 2024 (PDF)
  • Blood immune receptor repertoire and transcription profiling to characterize disease progression in a murine tuberculosis model, May 2024 (PDF)
  • Longitudinal multi-omic analysis of immune response to vaccination, May 2024 (PDF)
  • Targeted RNA-seq of dried blood microsamples for convenient RNA biomarker monitoring, April 2024 (PDF)
  • Evaluation of BCR control cell-lines and synthetic controls using DriverMap Adaptive Immune Receptor (AIR) profiling technology, April 2024 (PDF)
  • Single-cell TCRα/β and TCRγ/δ immune receptor profiling and immunophenotyping using a 96-well plate sorted-cell approach, April 2024 (PDF)
  • Universal synthetic TCR/BCR spike-in controls to evaluate immune receptor profiling assay and next-generation sequencing performance, April 2024 (PDF)
  • A flexible and efficient approach for single-cell CRISPR perturbation screens combined with targeted RNA-seq expression analysis, April 2024 (PDF)
  • CRISPR/saCas9 and CRISPR/spCas9 systems for combinatorial genetic screens (CRISPR-KO, CRISPRa, CRISPRi), April 2024 (PDF)
  • Universal synthetic spike-in controls for accurate adaptive immune receptor profiling, October 2023 (PDF)
  • Microsampling for RNA biomarker profiling in blood, October 2023 (PDF)
  • T-cell and B-cell receptor repertoire profiling for biomarker discovery, September 2023 (PDF) 
  • RNA transcriptome profiling in microsamples of blood, September 2023 (PDF)
  • CRISPR-Cas9 genome editing in iPSCs for functional genetic screening, June 2023 (PDF)
  • Perturb-seq analysis reveals key mediators of TNFα-induced transcriptional response, June 2023 (PDF)
  • T-cell and B-cell receptor repertoire profiling for biomarker discovery, May 2023 (PDF)
  • Improved T-cell and B-cell receptor repertoire profiling and immunophenotyping for biomarker discovery, April 2023 (PDF)
  • Ultra-sensitive TCR/BCR clonotyping and immunophenotyping, October 2022 (PDF)
  • CRISPR/Cas9 genome editing in iPSC for functional genetic screen applications, September 2022 (PDF)
  • Immunophenotyping of TCR and BCR Clonotypes, April 2022 (PDF)
  • Perturb-seq analysis of TNFalpha-induced transcriptional response, April 2022 (PDF)
  • CRISPRa Tools for Gain-of-Function Genetic Screens, October 2020 (MP4)
  • Cell Barcoding, Genetic Screens and Expression Profiling at a single-cell level, October 2020 (MP4)
  • CRISPRa Tools for Gain-of-Function Genetic Screens, February 2020 (PDF)
  • Combining Cell Barcoding and CRISPR sgRNA Libraries with Targeted Gene Expression for Single-Cell Genetic Analysis of Tumor Development, April 2019 (PDF)
  • Combining Barcode Libraries with Targeted Gene Expression Profiling for Single-Cell Genetic Analysis, June 2018 (PDF)
  • CRISPR/Cas9 Genome-Wide sgRNA Libraries for Loss-of-function and Gain-of-function Genetic Screens, Cell Symposia, October 2017 (PDF)
  • Profiling of Immunity Biomarkers in Whole Blood, AACR Annual Meeting, April 2017 (PDF)
  • CRISPR/Cas9 Genome-Wide gRNA Library for Target Identification, AACR Annual Meeting, April 2016 (PDF)
  • Cancer Immunotherapy Biomarker Profiling Assay, AACR Annual Meeting, April 2016 (PDF)
  • Cancer ImmuneNet™ Biomarker Profiling Assay, SITC, November 2015 (PDF)
  • Loss-of-function genetic screens to find genes regulating cell responses and identify potential drug targets, EORTC-NCI-AACR 2014 (PDF)
  • Pooled RNAi Genetic Screening to Identify Functional Genes and Novel Drug Targets, DOT, October 2013 (PDF)
  • Pooled RNAi screens in xenograft mouse models, AACR, April 2013 (PDF)
  • Identification of potential cancer drug targets in prostate, blood, and breast cancer cells using HT RNAi screening with pooled shRNA libraries, AACR, April 2011 (PDF)
  • HT Screening for bioactive peptides that increase radiation tolerance using a pooled lentiviral peptide scanning library, Gordon Research Conference, Antimicrobial Peptides, May 2011 (email us)
  • Development of Recombinant Protein Overproducer Cell Lines with Lentiviral Expression Vectors, IBC 4th Annual Cell Line Development and Engineering Conference, June 2008 (PDF)

For a list of the upcoming events we’re attending, please visit Cellecta’s Events page.